Table 3.
Multivariate survival analysis of OS in patients with LACSCC.
Clinicopathologic characteristics | B | SE | Wald | P value | HR | 95% CI |
---|---|---|---|---|---|---|
Lymph node metastasis | 0.626 | 0.516 | 1.475 | 0.225 | 1.870 | 0.681–5.139 |
FIGO stage | 0.188 | 0.495 | 0.144 | 0.704 | 1.207 | 0.457–3.185 |
NLR | −1.316 | 0.631 | 4.350 | 0.037 | 0.268 | 0.078–0.924 |
OS, overall survival; LACSCC, locally advanced cervical squamous cell carcinomas; FIGO, International Federation of Gynecology and Obstetrics; NLR, neutrophil-lymphocyte ratio.